1/81
Looks like no tags are added yet.
Synthetic biology
The design and construction of new biological "parts", "devices", and "systems"
redesign of existing natural biological systems for useful purposes
Synthetic biology as genetic engineering
Design-driven genetic engineering that encompasses the engineering concepts of standardization and rationalization
the new-generation, advanced form of genetic engineering
Technologies included under synthetic biology
Advanced genome-editing technologies such as CRISPR
cell-free synthesis of DNA/RNA/protein
Goal of synthetic biology
To extend or modify the behavior of natural organisms and engineer them to perform new tasks

Three major application areas of synthetic biology
Biomanufacturing (Biofuels, biochemicals, pharmaceuticals, food ingredients)
Biosensing (Disease diagnosis, drug discovery, food safety, pollution monitoring)
Therapy (Cancer targeting, immuno-modulation, microbiome modulation, cell therapy)
Genetic engineering vs synthetic biology: approach
Genetic engineering transfers genes from one organism to another
Synthetic biology designs and builds new biological systems from scratch
Genetic engineering vs synthetic biology: tools
Genetic engineering uses recombinant DNA technology, PCR, etc.; synthetic biology uses standardized genetic parts and engineering principles
Genetic engineering vs synthetic biology: goals
Genetic engineering makes minor modifications of existing organisms; synthetic biology makes major modifications or creates new organisms with desired properties
Genetic engineering vs synthetic biology: complexity
Genetic engineering typically modifies single genes; synthetic biology can modify entire genomes or create synthetic genomes
Three engineering concepts borrowed by synthetic biology
Modularity, standardization of parts, and mathematical description
Modularity
The practice of breaking a system into separate, independent modules that work together
Standardization of parts
Using a limited set of components or parts across multiple products or assemblies
Mathematical description
Using mathematical equations, concepts, and models to represent and understand bioprocess systems, enabling analysis, prediction, and rational design
Engineering-to-biology hierarchy analogy
Physical layer → gates → modules → computers → networks in electronics parallels proteins/genes → biochemical reactions → pathways → cells → tissues and cultures in biology
Disciplines that make up synthetic biology
Metabolic engineering, circuit construction, tool development, protein engineering, genome engineering, molecular biology, and computational biology
Biological part
A piece of DNA that forms a functional unit
Examples of biological parts
Promoters, terminators, ribosome binding sites (RBS), genes
Biological device
A set of complementary parts put together with a defined function
Biological system
A combination of a set of devices that performs high-level tasks
Parts/device/system hierarchy
DNA makes up parts; assemblies of parts make up devices; assemblies of devices make a system (analogous to spark plug → engine → car)
Why standardize biological parts
So biologists from different laboratories can work together on the same parts
Second purpose of standardization
To define rules and models that predict how a particular stretch of DNA — promoters, terminators, binding sites — works in the cell
Analogy used for lack of standardization
Incompatible charger cables
Three things that must be standardized in biology
Standard plasmids, interchangeable parts, and a standard method of assembly
Why standardization in biology is tricky (reality)
Many organizations and research groups have been developing their own standard parts, so no single standard dominates
BioBrick base vector
BBa_I51020, the default BioBrick base vector carrying standardized prefix, suffix, origin, selection marker and resistance parts
BBa_G00000 and BBa_G00001
The BioBrick cloning site prefix and the BioBrick cloning site suffix
BBa_P1016
ccdB positive selection marker
BBa_I50022
pUC19-derived high copy replication origin
BBa_B0042
Translational stop sequence
BBa_B0053 / BBa_B0054
Forward transcriptional terminators
BBa_B0055 / BBa_B0062
Reverse transcriptional terminators
BBa_G00100 and BBa_G00102
Forward verification primer annealing site (VF2) and reverse verification primer annealing site (VR)
BBa_B0045
NheI restriction site
BBa_P1006
Ampicillin resistance marker (reverse orientation)
Parts of a standard expression operating unit (EOU)
Upstream insulator, transcription element (promoter), translation initiation element (RBS/BCD), gene of interest (GOI), 3' UTR, transcription terminator, downstream insulator
Four biological devices covered in the lecture
Logic gates, genetic oscillator, toggle switch, and synthetic antisense RNA
Logic gate
The basic building block of any digital system — an electronic circuit with one or more inputs and only one output, where the input-output relationship follows a certain logic
Basic logic gates
AND gate, OR gate, NOT gate
AND gate
The output is true only when all of the inputs are true
OR gate
The output is true when one or more of its inputs are true
NOT gate (inverter)
Performs logical negation on its input
Logical AND gate in synthetic biology
If Signal A AND Signal B are present, the desired gene product results; each signal activates expression of a separate gene, and the expressed proteins form a complete complex capable of activating output expression
Logical OR gate in synthetic biology
If Signal A OR Signal B is present, the desired gene product results; either signal alone can activate the output gene, and only the action of a single promoter is required
Oscillator
A device that generates a periodic or oscillating signal
Repressilator
A genetic regulatory network consisting of at least one feedback loop with at least three genes, each expressing a protein that represses the next gene in the loop
Repressilator architecture
Repressor 1 represses repressor 2, repressor 2 represses repressor 3, and repressor 3 represses repressor 1, producing out-of-phase oscillating protein levels over time
Possible application of the repressilator
Intermittent administration of a therapeutic protein
Synthetic antisense RNA (definition)
A short reversed complementary sequence of mRNA used as a tool for controlling gene expression in a cell
How antisense oligonucleotides act
They target genes at the level of mRNA and prevent them from producing proteins
Properties of synthetic antisense RNAs
Non-natural, short, single-stranded nucleotides that inhibit the transcription of target genes
How antisense RNA binds its target
With high specificity to complementary mRNA sequences by Watson and Crick base pairing, forming a dimer, in the same manner as DNA replication and RNA transcription
Two ways antisense RNA blocks protein synthesis
By occupying the mRNA and preventing ribosome access (blocking translation and splicing), or by targeting the dimer for degradation by ribonuclease H1
Inhibition range of finetuned antisense RNAs
Controllable inhibition of 10–80%
Toggle switch
A well-characterized bistable biological circuit with two stable equilibrium states, in which either of the two gene products represses expression of the other gene
Stability of the toggle switch
Once cells are committed to an equilibrium state they remain in it even in the presence of small perturbations
Genes used in the classic toggle switch
cI and lacI — cI represses lacI expression in one state, and LacI represses cI expression in the other
Promoters used in the genetic toggle switch
P_L* drives λ cI and P_trc drives lacI, each repressing the other so one is ON while the other is OFF
How to induce a transition from the high CI state
By degrading CI or by introducing additional LacR molecules
How λ CI proteolysis is triggered in the toggle switch
Through RecA-mediated proteolysis during induction, which drops λ CI activity and lets LacR activity rise
Panel B of the toggle switch figure
A simulated transition induced when the rate of CI proteolysis is temporarily increased under inducing conditions
Why tumor-killing bacteria are useful
They can colonize tumor cells, making them a promising drug delivery system
Gene hlyE
Produces the therapeutic protein that kills tumor cells in the engineered tumor-treatment circuit
Quorum sensing (QS)
A system of cell-to-cell communication used by bacteria to sense their population density and coordinate behaviors as a group
LuxI
An enzyme that synthesizes AHLs (acyl-homoserine lactones), the signaling molecules used in quorum sensing
Role of LuxR
When AHLs reach a certain concentration they bind LuxR; the AHL–LuxR complex then binds lux boxes and activates transcription
What happens at high cell density in the tumor circuit
The quorum sensing system senses the cell population and triggers cell lysis, releasing the therapeutic protein
Role of GFP in the tumor-treatment circuit
A reporter and indicator for cell number
Circuit components in the tumor-treatment design
Therapeutic module (hlyE) and reporter module (sfGFP) controlled by LuxR-AHL, with luxI as the activator and φX174E driving lysis
Three phases shown in the synchronized lysis figure
Growth, reaching the quorum threshold, and synchronized lysis — producing repeating fluorescence/bacteria oscillations over ~20 h
Bifunctional sensor-regulator system
A system in which metabolites act on a promoter so that antisense RNA down-regulates genome targets while repressors/promoters up-regulate pathway genes
Advantage of a sensor-regulation system
It can dynamically activate transcription through an inducible promoter
Advantage of combining antisense RNA with a sensor regulator
It achieves simultaneous up- and down-regulation of different genes
Muconic acid example of the sensor-regulator system
Glycerol feeds E4P/PEP to DAHP and chorismate; the EP module (entC, pchB) makes salicylate and the NC module (nahG, CatA) makes catechol then muconic acid, while ppc, pykF and pykA are down-regulated
Artemisinin case study
Metabolic engineering/synthetic biology production of artemisinin in microorganisms via the heterologous mevalonate pathway in E. coli and yeast
Artemisinin pathway outline in E. coli
Acetyl-CoA → mevalonate → FPP → amorphadiene → artemisinic acid, which is then converted to artemisinin
Top Pathway (plasmid 1, MevT) genes
atoB, ERG13, tHMG1 — converting acetyl-CoA to AA-CoA, HMG-CoA, and mevalonate
Bottom Pathway (plasmid 2, MBIS) genes
ERG12, ERG8, MVD1, idi, ispA — converting Mev → Mev-P → Mev-PP → IPP ⇄ DMAPP → FDP
Plasmid 3 (pADS)
Carries ADS (amorphadiene synthase) alone, converting FDP to amorpha-4,11-diene
Enzyme gene abbreviations in the artemisinin pathway
atoB acetoacetyl-CoA thiolase; ERG13 HMG-CoA synthase; tHMG1 truncated HMG-CoA reductase; ERG12 mevalonate kinase; ERG8 phosphomevalonate kinase; MVD1 mevalonate pyrophosphate decarboxylase; idi IPP isomerase; ispA farnesyl pyrophosphate synthase; ADS amorphadiene synthase
Source organisms for the artemisinin pathway
Enzymes from 3 species — atoB, idi and ispA from E. coli (blue), ERG13, tHMG1, ERG12, ERG8 and MVD1 from yeast (brown), and ADS from Artemisia annua (red) — plus extensive modification of individual steps
Artemisinin titer progression
Initial attempts yielded ~0.1 g/L; 2009 reached ~25 g/L in E. coli; 2012 reached ~40 g/L in yeast by optimizing enzyme expression levels